Literature DB >> 16474147

A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.

Melody R Davis1, Jiyang Jiang, Jing Zhou, Eric O Freed, Christopher Aiken.   

Abstract

The Gag protein of human immunodeficiency virus type 1 (HIV-1) associates with the envelope protein complex during virus assembly. The available evidence indicates that this interaction involves recognition of the gp41 cytoplasmic tail (CT) by the matrix protein (MA) region of Pr55(Gag). Here we show that substitution of Asp for Leu at position 49 (L49D) in MA results in a specific reduction in particle-associated gp120 without affecting the levels of gp41. Mutant virions were markedly reduced in single-cycle infectivity despite a relatively modest defect in fusion with target cells. Studies with HIV-1 particles containing decreased levels of envelope proteins suggested that the L49D mutation also inhibits a postentry step in infection. Truncation of the gp41 tail, or pseudotyping by vesicular stomatitis virus glycoprotein, restored both the fusion and infectivity of L49D mutant virions to wild-type levels. Truncation of gp41 also resulted in equivalent levels of gp120 on particles with and without the MA mutation and enhanced the replication of the L49D mutant virus in T cells. The impaired fusion and infectivity of L49D mutant particles were also complemented by a single point mutation in the gp41 CT that disrupted the tyrosine-containing endocytic motif. Our results suggest that an altered interaction between the MA domain of Gag and the gp41 cytoplasmic tail leads to dissociation of gp120 from gp41 during HIV-1 particle assembly, thus resulting in impaired fusion and infectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474147      PMCID: PMC1395406          DOI: 10.1128/JVI.80.5.2405-2417.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.

Authors:  R J Owens; J W Dubay; E Hunter; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

Authors:  J A McKeating; A McKnight; J P Moore
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.

Authors:  H Andreassen; H Bohr; J Bohr; S Brunak; T Bugge; R M Cotterill; C Jacobsen; P Kusk; B Lautrup; S B Petersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.

Authors:  S D Gowda; B S Stein; E G Engleman
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

6.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

7.  p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.

Authors:  N Sharova; A Bukrinskaya
Journal:  AIDS Res Hum Retroviruses       Date:  1991-03       Impact factor: 2.205

8.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

Authors:  J P Moore; J A McKeating; R A Weiss; Q J Sattentau
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

9.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

Authors:  D H Smith; R A Byrn; S A Marsters; T Gregory; J E Groopman; D J Capon
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

10.  Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.

Authors:  Christopher A Lundquist; Jing Zhou; Christopher Aiken
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  44 in total

1.  Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure.

Authors:  Ruba H Ghanam; Timothy F Fernandez; Emily L Fledderman; Jamil S Saad
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

2.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

3.  Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion.

Authors:  Sundaram A Vishwanathan; Eric Hunter
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

4.  Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.

Authors:  Antonio Trabalza; Ioanna Eleftheriadou; Argyro Sgourou; Ting-Yi Liao; Petros Patsali; Heyne Lee; Nicholas D Mazarakis
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

5.  Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

Authors:  S Alireza Rabi; Gregory M Laird; Christine M Durand; Sarah Laskey; Liang Shan; Justin R Bailey; Stanley Chioma; Richard D Moore; Robert F Siliciano
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

6.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Authors:  Ayna Alfadhli; August O Staubus; Philip R Tedbury; Mariia Novikova; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.

Authors:  Kei Sato; Jun Aoki; Naoko Misawa; Eriko Daikoku; Kouichi Sano; Yuetsu Tanaka; Yoshio Koyanagi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 9.  The roles of tetraspanins in HIV-1 replication.

Authors:  Markus Thali
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.